Search
AxoGen Inc
AXGNAdd to Watchlist
42.210USD
+0.860+2.08%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.27BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of AxoGen Inc is 8.40, ranking 41 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 36.00, with a high of 40.00 and a low of 27.00.
Analyst Rating
Based on
9
analysts
Buy
Current Rating
53.222
Target Price
+26.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
AxoGen Inc
AXGN
9
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is AxoGen Inc's expected revenue for the next quarter?
AxoGen Inc's expected revenue is 73.19M.
What is AxoGen Inc's price target?
Analysts forecast that AxoGen Inc's price target is USD 36.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 27.00.
How have AxoGen IncAXGN's recent earnings per share performed?
The market expectation was USD -0.03, while AxoGen IncAXGN's earnings per share (EPS) for the previous quarter was USD -0.38. EPS for the next quarter is expected at USD 0.13.
What is the analyst rating for AxoGen Inc?
Based on the ratings of AxoGen Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.